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Background
People following gluten free diets have
become increasingly prevalent. Many people
indicate that they feel better on a gluten free
diet and that their symptoms return after
eating gluten. This is occurring in the
absence of celiac disease or a wheat allergy.
This new clinical entity is called non-celiac
gluten sensitivity (NCGS). Volta and
colleagues (2014) cite several reasons for an
increase in this condition: 1) farming
practices have led to an increase in specific
wheat variants that contain high amounts of
gluten peptides that maybe toxic to
susceptible individuals; 2) dough
fermentation has significantly been
shortened compared to the sourdough
method used by traditional cultures. Shorter
fermentation times results in higher levels of
toxic gluten fractions; 3) high intake of gluten
containing foods in general may play a role in
triggering symptoms; and 4) media hype
claims that gluten free diets are healthier,
leading many people to believe that gluten is
toxic.1 Due to lack of serological and
histological tests, the existence of NCGS has
been considered controversial. The purpose
of this review is to present recent evidence
that indicates NCGS is an emerging spectrum
of gluten intolerance.

Methods
Academic Search Complete was searched
using the key words "non-celiac gluten
sensitivity" and "non-celiac wheat sensitivity."
The search was limited to peer-reviewed
original research articles and review articles,
published in English and from the years 2000
to 2016. Further references were utilized from
the bibliography of the chosen articles.

Discussion
The term NCGS was established by the Second
Expert Meeting in Munich in 2012.2
Symptoms
Symptoms of NCGS include gastrointestinal
symptoms (similar to irritable bowel
syndrome) and extra-intestinal symptoms.

Discussion
Carroccio and collegues5 found that a
hallmark characteristic of NCGS was
eosinophil (innate immune leukocytes)
infiltration of the duodenal and colon mucosa.

Table I. Symptom prevalence of patients with nonceliac gluten sensitivity (NCGS) observed at the
Department of Medical and Surgical Sciences of the
University of Bologna over the last 12 months.
NCGS patients 84/2340 (3.5%); mean age 38 years (range
16-65 years); Female/Male: 3.7:1*
Gastrointestinal %
Extra-intestinal %
symptoms
symptoms
Abdominal pain 84
Tiredness
78
Bloating
84
Headache
55
Diarrhea
55
Foggy Mind
40
Nausea or
50
Anxiety
38
vomiting
Gastric Pain
48
Joint/muscle
30
pain
fibromyalgia like
Heartburn
45
Numbness
30
(arms, legs,
fingers)
Aerophagia
35
Skin
27
rash/dermatitis
Aphthous
30
Anemia
22
stomatitis
Gastro30
Weight loss
10
esophageal
reflux disease
Altered bowel 27
Rhinitis
9
habits
Constipation
24
Asthma
5

Source: Volta and colleagues, 2014

Diagnostic Criteria
Biochemical markers to identify NCGS from
celiac disease are associated with the
activation of the innate immune system and
in some cases, increased intestinal
permeability.3

Discussion
Products containing wheat and rye contain
high amounts of fructans and galactooligosaccharides. Other grains, such as rice,
oat, quinoa and corn contain very low levels.5
Due to factors other than gluten, researchers
suggest using the term non-celiac wheat
sensitivity instead of non-celiac gluten
sensitivity.4
Important Points
It is important to rule out celiac disease and
wheat allergy prior to instituting a gluten free
diet.6 Markers to distinguish celiac disease
from NCGS are actively being researched. Food
challenge is still a useful tool. Experts
recommend food challenge with wheat to be
performed after at least 6 weeks of being on a
gluten-free diet.7 A subset of patients who
have wheat sensitivity will also have multiple
food hypersensitivities.4

Conclusion

Source: Mocan and Dumitrascu, 2010

Components in Wheat that Cause Symptoms
Several components in wheat/gluten contribute
to symptoms: 1) undigested gluten peptidesspecifically gliadin peptides;3 2) αamylase/trypsin inhibitors (ATIs)-low molecular
weight proteins in wheat that stimulate the
innate immune response;5 3) wheat lectin
agglutinin (WGA)-a lectin found in wheat that has
been shown to increase intestinal permeability
and stimulate the immune system;5 4) and
carbohydrate containing fructans and galactans
(members of fermentable oligosaccharide,
disaccharide, mono-saccharides, and polyols
(FODMAPS).

Patient quality of life can be severely impacted
by continuing to ingest gluten in the presence
of NCGS. With the recent publications of high
quality clinical research studies, it is clearly
obvious that non-celiac gluten sensitivity is a
valid condition. Nutrition professionals need to
be aware of the current evidence supporting
this condition.
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